Rudolf Jaenisch

USPTO Granted Patents = 34 (Patent Applications = 20)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 375(Granted Patents)

Location History:

Cambridge, MA (US) (2017 - 2021)
Brookline, MA (US) (2004 - 2024)

Company Filing History:

32 out of 303

Whitehead Institute for Biomedical Research

patents

2 out of 8,373

Massachusetts Institute of Technology

patents

2 out of 160

Sangamo Biosciences, Inc.

patents

4. 1 out of 145

Sangamo Therapeutics, Inc.

patents

5. 1 out of 1,209

Dana-farber-cancer Institute Inc.

patents

6. 1 out of 1,586

Washington University

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371667 - Enhanced methods for inducing and maintaining naive human pluripotent stem cells (2025-07-29),

2. 12123019 - Uses of kinase inhibitors for inducing and maintaining pluripotency (2024-10-22),

3. 12060588 - Methods of editing DNA methylation (2024-08-13),

4. 12053465 - KCC2 expression enhancing compounds and uses thereof (2024-08-06),

5. 11987815 - Methods for reprogramming somatic cells (2024-05-21),

6. 11851670 - Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides (2023-12-26),

7. 11655459 - Methods for reprogramming somatic cells (2023-05-23),

8. RE49281 - Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors (2022-11-07),

9. 11434476 - Methods of editing DNA methylation (2022-09-06),

10. 11331313 - KCC2 expression enhancing compounds and uses thereof (2022-05-17),

11. 11136548 - Culture medium for generating microglia from pluripotent stem cells and related methods (2021-10-05),

12. 10457917 - Methods for reprogramming somatic cells (2019-10-29),

13. 10093904 - Reprogramming of somatic cells (2018-10-09),

14. 10023922 - Reporter of genomic methylation and uses thereof (2018-07-17),

15. 10017744 - Methods for reprogramming somatic cells (2018-07-10),

Title: The Innovative Journey of Rudolf Jaenisch

Introduction: Rudolf Jaenisch, a distinguished male inventor based in Brookline, MA (US), has made significant contributions to the field of biotechnology and genetics through his groundbreaking research and inventions.

Latest Patents: Rudolf Jaenisch holds several patents in the field of gene editing and stem cell technology, with his most recent patent focusing on a novel method for targeted gene modification in mammalian cells.

Career Highlights: With a career spanning several decades, Rudolf Jaenisch has been at the forefront of pioneering research in genetic engineering, particularly in the development of induced pluripotent stem cells (iPSCs) and their applications in regenerative medicine.

Collaborations: Throughout his career, Rudolf Jaenisch has collaborated with leading scientists and research institutions worldwide, fostering innovation and knowledge exchange in the field of biotechnology.

Conclusion: Rudolf Jaenisch's relentless pursuit of innovation and his groundbreaking inventions have not only advanced the field of genetics and biotechnology but have also paved the way for new possibilities in regenerative medicine and personalized healthcare.

This text is generated by artificial intelligence and may not be accurate.